| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exec. Chair &Principal Off | Exec. Chair &Principal Off. | See Remarks +5 more
3 companies
Armen Garo H is a Director at MiNK Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 10 buys and 2 sells.
Estimated insider holdings value: $23.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | PTIX Protagenic Therapeutics, Inc. | Exec. Chair &Principal Off | Buy | 5,000 | $0.26 | $1,294.00 | +19.0% | - | - | |
| Jul 30, 2026 | PTIX Protagenic Therapeutics, Inc. | Exec. Chair &Principal Off. | Buy | 26,291 | $0.18 | $4,805.99 | New | - | - | |
| Feb 15, 2024 | AGEN Agenus Inc | See Remarks | Buy | 500,000 | $0.65 | $324,050.00 | +396.9% | -17.6% | -73.2% | |
| May 5, 2023 | INKT Mink Therapeutics, Inc. | Director | Sell | 100,000 | $0.95 | $94,850.00 | -5.1% | +8.9% | -38.0% | |
| May 2, 2023 | INKT Mink Therapeutics, Inc. | Director | Buy | 100,000 | $0.95 | $94,850.00 | +5.3% | +110.1% | +7.0% | |
| Sep 13, 2021 | AGEN Agenus Inc | Chairman And CEO | Sale+OE | 82,107 | $6.50 | $533,695.50 | -9.6% | -49.4% | -60.8% | |
| Apr 12, 2017 | AGEN Agenus Inc | Chairman &CEO | Buy | 100,000 | $3.35 | $334,519.79 | +3.7% | - | - | |
| Jun 17, 2016 | PTIX Protagenic Therapeutics, Inc.\new | See Remarks | Buy | 60,211 | $1.25 | $75,263.75 | +1.4% | - | - | |
| May 9, 2016 | AGEN Agenus Inc | Chairman &CEO | Buy | 100,000 | $3.18 | $317,895.00 | +3.8% | - | - | |
| Mar 7, 2016 | AGEN Agenus Inc | Chairman &CEO | Buy | 200,000 | $4.03 | $805,600.00 | +19.0% | - | - |